Benzinga | Aug 16, 2021 06:40AM EDT

Entera Bio Q2 EPS $(0.20) Misses $(0.12) Estimate, Sales $109.00K Beat $90.00K Estimate

Entera Bio (NASDAQ:ENTX) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.12) by 66.67 percent. This is a 17.65 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $109.00 thousand which beat the analyst consensus estimate of $90.00 thousand by 21.11 percent. This is a 109.62 percent increase over sales of $52.00 thousand the same period last year.